SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016841
Filing Date
2019-05-08
Accepted
2019-05-08 08:03:18
Documents
54
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 2019 FORM 10-Q FOR PERIOD ENDED MARCH 31, 2019 alna-10q_20190331.htm 10-Q 1658293
2 EX-31.1 alna-ex311_7.htm EX-31.1 16713
3 EX-31.2 alna-ex312_6.htm EX-31.2 16704
4 EX-32.1 alna-ex321_8.htm EX-32.1 10195
  Complete submission text file 0001564590-19-016841.txt   4503062

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT alna-20190331.xml EX-101.INS 724242
6 XBRL TAXONOMY EXTENSION SCHEMA alna-20190331.xsd EX-101.SCH 35832
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alna-20190331_cal.xml EX-101.CAL 36471
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alna-20190331_def.xml EX-101.DEF 114206
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE alna-20190331_lab.xml EX-101.LAB 284729
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alna-20190331_pre.xml EX-101.PRE 215228
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38268 | Film No.: 19805243
SIC: 2836 Biological Products, (No Diagnostic Substances)